V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200003247 | 200018594 | 1.72 | null | null | null | 2020-05-09 | null | null | null | TRIAL UNSPECIFIED | 100188585 |
| 200003503 | 200018595 | 1.78 | 74.6 | Palliative (P) | null | 2018-04-21 | null | null | N | TRAMETINIB | 100917893 |
| 200003908 | 200018597 | null | 74.6 | 03 | null | 2020-03-06 | null | null | N | TRAMETINIB | 100427362 |
| 200003952 | 200018598 | 1.61 | 110 | Palliative (P) | null | 2018-12-23 | null | null | N | IPILIMUMAB + NIVOLUMAB | 101809717 |
| 200004203 | 200018601 | 1.83 | null | null | null | 2022-05-25 | null | null | null | TRIAL UNSPECIFIED | 101530997 |
| 200004283 | 200018604 | null | null | null | null | 2021-08-01 | null | null | null | CTD | 100740750 |
| 200004626 | 200018607 | 1.74 | 80.3 | Palliative (P) | null | 2021-11-05 | null | null | N | TRAMETINIB | 101472557 |
| 200004713 | 200018608 | 1.73 | 89 | Palliative (P) | null | 2018-09-08 | null | null | N | CAPECITABINE | 101535624 |
| 200004945 | 200018612 | 1.5 | null | null | null | 2020-12-22 | null | null | null | INTERIM TRIAL | 100693030 |
| 200005062 | 200018613 | null | 48.4 | Disease modification (D) | null | 2018-12-08 | null | null | N | IPILIMUMAB + NIVOLUMAB | 100644329 |
| 200005167 | 200018614 | null | 74.5 | Palliative (P) | 2021-04-21 | 2021-08-06 | null | 01 | N | IPILIMUMAB + NIVOLUMAB | 101209454 |
| 200005536 | 200018621 | 1.66 | null | null | null | 2020-11-20 | null | null | null | IPILIMUMAB + NIVOLUMAB | 101199012 |
| 200005555 | 200018622 | 1.83 | null | null | null | 2022-05-02 | null | null | null | BINIMETINIB + ENCORAFENIB | 100953160 |
| 200005721 | 200018623 | 1.77 | 0 | Disease modification (D) | 2020-04-13 | 2020-04-27 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100787801 |
| 200006262 | 200018625 | 1.58 | 105.7 | Palliative (P) | 2020-11-10 | 2020-11-10 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100239813 |
| 200006465 | 200018627 | null | 68.2 | Palliative (P) | 2021-07-04 | 2021-07-11 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100763139 |
| 200006535 | 200018629 | 1.71 | null | null | null | 2021-07-16 | null | null | null | INTERIM TRIAL | 101860574 |
| 200006789 | 200018632 | 1.65 | 56 | Palliative (P) | null | 2017-04-25 | null | null | N | INTERIM TRIAL | 100580319 |
| 200006828 | 200018633 | 1.88 | null | null | null | 2019-12-07 | null | null | null | IPILIMUMAB + NIVOLUMAB | 100839905 |
| 200000550 | 200018634 | 1.68 | 90.4 | Palliative (P) | null | 2019-09-10 | null | null | N | IPILIMUMAB | 100673848 |
| 200002334 | 200018637 | 1.68 | null | null | null | 2018-05-17 | null | null | null | TRIAL | 101198230 |
| 200003163 | 200018638 | 1.82 | 74.2 | Adjuvant (A) | null | 2017-12-16 | null | null | null | BCG | 101119163 |
| 200004326 | 200018639 | null | 60 | Adjuvant (A) | 2020-10-23 | 2020-10-28 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100369566 |
| 200004838 | 200018641 | null | null | null | null | 2021-11-16 | null | null | null | TRIAL UNSPECIFIED | 100431198 |
| 200006771 | 200018643 | 1.5 | null | null | null | 2020-05-12 | null | null | null | DOCETAXEL | 101050905 |
| 200000550 | 200018644 | null | 95.4 | Palliative (P) | null | 2021-01-27 | null | null | null | TALIMOGENE LAHERPAREPVEC | 100673848 |
| 200001809 | 200018646 | null | 77.95 | Palliative (P) | 2020-02-19 | 2020-03-18 | null | 01 | N | IPILIMUMAB + NIVOLUMAB | 101608452 |
| 200001791 | 200018673 | null | 95 | Palliative (P) | null | 2017-02-11 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100299648 |
| 200001795 | 200018674 | null | 86.7 | Palliative (P) | 2019-09-30 | 2019-10-03 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101859489 |
| 200001800 | 200018675 | null | null | Adjuvant (A) | 2022-01-28 | 2022-02-10 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100208974 |
| 200001844 | 200018676 | 1.65 | 85 | null | 2021-02-06 | 2021-11-21 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101316499 |
| 200001938 | 200018677 | 1.76 | 76.8 | null | null | 2021-09-14 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100105737 |
| 200001981 | 200018678 | null | null | Palliative (P) | null | 2020-12-31 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101306866 |
| 200001986 | 200018679 | null | null | null | null | 2021-02-10 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100607586 |
| 200002055 | 200018681 | null | 83.45 | null | null | 2021-09-11 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101132147 |
| 200002120 | 200018683 | 1.5 | 75.2 | Palliative (P) | 2022-04-21 | 2022-05-13 | PEMBROLIZUMAB | null | N | PEMBROLIZUMAB | 101509902 |
| 200002141 | 200018684 | null | null | null | null | 2022-02-25 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100092038 |
| 200002210 | 200018686 | null | null | Palliative (P) | 2016-08-11 | 2016-10-06 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101514417 |
| 200002349 | 200018687 | null | null | Adjuvant (A) | 2019-02-02 | 2019-04-13 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101046537 |
| 200002415 | 200018691 | 1.7 | 72.8 | null | 2019-08-13 | 2019-08-19 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100568779 |
| 200002711 | 200018697 | 1.78 | 126.3 | Palliative (P) | null | 2019-03-02 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100760207 |
| 200002828 | 200018700 | 1.84 | null | Adjuvant (A) | null | 2021-01-15 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100680987 |
| 200003039 | 200018702 | null | 77.3 | null | 2021-06-22 | 2021-07-01 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101654005 |
| 200003211 | 200018703 | 1.81 | 98.5 | null | null | 2016-06-06 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 101715704 |
| 200003296 | 200018704 | 0 | 84 | Palliative (P) | 2021-11-08 | 2021-12-05 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101404656 |
| 200003330 | 200018706 | 1.53 | 70.2 | null | null | 2019-02-04 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100070169 |
| 200003339 | 200018707 | null | null | null | null | 2017-10-15 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100351026 |
| 200003455 | 200018709 | 1.62 | null | null | 2018-11-05 | 2018-11-12 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 101089273 |
| 200003545 | 200018712 | 1.81 | 91.8 | Adjuvant (A) | 2022-05-07 | 2022-05-07 | PEMBROLIZUMAB | null | N | PEMBROLIZUMAB | 100076667 |
| 200003794 | 200018718 | 1.84 | 90.1 | Palliative (P) | 2018-10-02 | 2018-10-11 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101324737 |